Nebenwirkungen · Visudyne
Visudyne 15 mg powder for solution for infusion · Abschnitt 4.8 · PDF-Seite 6
HOS-091167 · Präparat HOS-084217
Immune system disorders Common Hypersensitivity1. Not known Anaphylactic reaction. Metabolism and nutrition disorders Common Hypercholesteraemia. Nervous system disorders Common Syncope, headache, dizziness1. Uncommon Hyperesthesia. Not known Vasovagal reactions1. Eye disorders Common Severe reduced visual acuity2, visual impairment such as reduced visual acuity, blurred, fuzzy vision, or photopsia, visual field defect such as scotoma, grey or dark haloes and black spots. Uncommon Retinal detachment, retinal haemorrhage, vitreous haemorrhage, retinal oedema. Rare Retinal ischaemia (retinal or choroidal vessel non-perfusion). Not known Retinal pigment epithelial tear, macular oedema. Cardiac disorders Not known Myocardial infarction3. Vascular disorders Uncommon Hypertension. Respiratory, thoracic and mediastinal disorders Common Dyspnoea1. Gastrointestinal disorders Common Nausea. Skin and subcutaneous tissue disorders Common Photosensitivity reaction4. Uncommon Rash, urticaria, pruritus1.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2020-09-16T02:00:00Z · SHA-256 3a3a3265d23eb5f145bd1d9db856c217528e19c50286f67e0a8227d1e7e2b879 · Passage bd1610386460b927b9b463916abcf6e271353beefea015fc921b619ad77fe061 · Zeichen 1028–2480 im Abschnitt